|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-4-11
|
|
pubmed:abstractText |
In recent years evidence has accumulated to implicate a disturbance in serotonin function in the eating disorder bulimia nervosa. This study employs a neuroendocrine technique to assess the effect of intravenous 5-hydroxytryptophan, the immediate precursor to serotonin, on peripheral hormones in bulimia nervosa subjects and controls. Blunted prolactin and growth hormone responses were observed among bulimia nervosa subjects; the possible pathophysiology and implications of the findings are discussed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0022-3999
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
289-97
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8861125-5-Hydroxytryptophan,
pubmed-meshheading:8861125-Adult,
pubmed-meshheading:8861125-Bulimia,
pubmed-meshheading:8861125-Female,
pubmed-meshheading:8861125-Human Growth Hormone,
pubmed-meshheading:8861125-Humans,
pubmed-meshheading:8861125-Hydrocortisone,
pubmed-meshheading:8861125-Infusions, Intravenous,
pubmed-meshheading:8861125-Prolactin,
pubmed-meshheading:8861125-Serotonin
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa.
|
|
pubmed:affiliation |
Department of Psychiatry, The Clarke Institute, University of Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
